Companies › Idorsia Pharmaceuticals US Inc.

Idorsia Pharmaceuticals US Inc.

Company Pharma & Medical Devices

Idorsia Pharmaceuticals US Inc. is listed as a company in Pharma & Medical Devices. It has filed 1 comment letter on 1 proposed federal rule in 2026, most often with the Drug Enforcement Administration.

Type
Company
Industry
Pharma & Medical Devices
Comment letters
1
Rules commented on
1
First letter
2026-09-11
Latest letter
2026-09-11
Agencies most often
Drug Enforcement Administration (1)

Activity by year

20261

Letters

2026

Schedules of Controlled Substances: Rescheduling of Suvorexant, Lemborexant, and Daridorexant From Schedule IV Into Schedule V

DEA-2026-1321Justice Department, Drug Enforcement Administration · filed 2026-09-11